ArticlePakistan journal of medical sciences2024
Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance.
Ruifen Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.